Found: 12
Select item for more details and to access through your institution.
Genome-wide CRISPR screen identifies protein pathways modulating tau protein levels in neurons.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02272-1
- By:
- Publication type:
- Article
P4-333: NAP reduces phosphorylated tau in AD transgenic mice
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P4-297: Development of full-length mouse amyloid beta ELISA and determination of endogenous Abeta level in BACE1 knockout mice
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P4-333: NAP reduces phosphorylated tau in AD transgenic mice
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P4-297: Development of full-length mouse amyloid beta ELISA and determination of endogenous Abeta level in BACE1 knockout mice
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage.
- Published in:
- Journal of Molecular Neuroscience, 2007, v. 31, n. 2, p. 165, doi. 10.1385/JMN/31:02:165
- By:
- Publication type:
- Article
Seizure reduction in TSC2‐mutant mouse model by an mTOR catalytic inhibitor.
- Published in:
- Annals of Clinical & Translational Neurology, 2023, v. 10, n. 10, p. 1790, doi. 10.1002/acn3.51868
- By:
- Publication type:
- Article
Deglycosylated anti-amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration.
- Published in:
- European Journal of Neuroscience, 2007, v. 26, n. 9, p. 2458, doi. 10.1111/j.1460-9568.2007.05852.x
- By:
- Publication type:
- Article
Generation and characterization of a rabbit monoclonal antibody site-specific for tau O-GlcNAcylated at serine 400.
- Published in:
- FEBS Letters, 2013, v. 587, n. 22, p. 3722, doi. 10.1016/j.febslet.2013.09.042
- By:
- Publication type:
- Article
Novel non-carbohydrate O-GlcNAcase inhibitors with CNS drug properties as potential treatment for Alzheimer's disease and tauopathies.
- Published in:
- 2013
- By:
- Publication type:
- Abstract
Kaleidoscope.
- Published in:
- AMA Journal of Ethics, 2018, v. 20, n. 9, p. 894, doi. 10.1001/amajethics.2018.894
- By:
- Publication type:
- Article
BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice.
- Published in:
- Journal of Neurochemistry, 2006, v. 99, n. 6, p. 1555, doi. 10.1111/j.1471-4159.2006.04178.x
- By:
- Publication type:
- Article